BioSpace News Archive

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, announced the hiring of David McMullin to the newly created position of Senior Vice President, Corporate Development and Strategy.

Objective of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics for AVB-S6-500

The Board of Directors of AmerisourceBergen Corporation today declared a quarterly dividend of $0.38 per common share

FT-2102 IDH1m Inhibitor Clinical Data Selected for Oral Presentation

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced its support for World Lupus DayTM with activities focused on raising awareness of lupus nephritis (LN)

May 10, 2018 12:05 UTC Motus GI to Present Data at Digestive Disease Week® 2018 Showing Pure-Vu® System May Reduce Costs and Incidence of Colorectal Cancer FORT LAUDERDALE, Fla.--( BUSINESS WIRE )-- Motus GI Holdings, Inc. , (NASDAQ:MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today that data related to the Company’s Pure-Vu® System will

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that Amit D. Munshi, President and Chief Executive Officer, will present at the following investor conferences

ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced the opening of its new subsidiary in Netherlands to support the company’s expansion into key European markets and provide on-the-ground sales and customer support for current clients, prospects and partners in the region.

Twenty abstracts including eight oral presentations to showcase Jazz’s breadth and depth of sleep medicine innovation [10-May-2018] Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting Twenty abstracts including eight oral pre

Diplomat Pharmacy, Inc. (NYSE: DPLO) (“Diplomat” or the “Company”) today announced that its Board of Directors has appointed Brian Griffin, Executive Vice President and CEO of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, Inc. (NYSE: ANTM), as Chief Executive Officer and Chairman of the Board of Directors, effective June 4, 2018.